Pharmaceutical manufacturer for Evogliptin

Dong-A has held the position of the largest pharmaceutical company in Korea since 1967. Our predominant market presence is attributed to internally developed products such as Suganon tab, Evogliptin, which is a DPP-4 inhibitor for type 2 diabetes mellitus, Zydena tab, which is Udenafil, the fourth PDE5 inhibitor globally for erectile dysfunction, Stillen tab, a herbal treatment for gastritis with Eupatilin, and Motilitone tab, which contains Corydaline for functional dyspepsia. Additionally, we provide branded generic drugs (anti-cancer, anti-TB, etc.), bio-pharmaceutical, IMD, APIs, and OTC products.

ST Pharm has provided exceptional custom production services for oligonucleotides and small molecule APIs CDMO to fulfill clients’ elevated requirements in pharmaceutical development while adhering to cGMP regulations. The enhancement of oligonucleotide manufacturing capabilities has emerged as a new driving force for the future of the pharmaceutical industry